# Neutrophil Gelatinase-Associated Lipocalin (NGAL) Rapid Test (Colloidal Gold) Clinical Trial Protocol

> **NCT05450523** · — · COMPLETED · sponsor: **Qingdao HIGHTOP Biotech Co., Ltd.** · enrollment: 220 (actual)

## Conditions studied

- Peritoneal Dialysis-associated Peritonitis

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT05450523
- **Lead sponsor:** Qingdao HIGHTOP Biotech Co., Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2021-12-28
- **Primary completion:** 2022-09-07
- **Final completion:** 2022-09-07
- **Target enrollment:** 220 (ACTUAL)
- **Last updated:** 2023-03-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05450523

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05450523, "Neutrophil Gelatinase-Associated Lipocalin (NGAL) Rapid Test (Colloidal Gold) Clinical Trial Protocol". Retrieved via AI Analytics 2026-06-12 from https://api.ai-analytics.org/clinical/NCT05450523. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*